 | | | | Shanghai ordered its 26 million residents to undergo two more rounds of tests as public anger mounts. | | | | | | Hong Kong health authorities reported 3,709 new COVID-19 cases on Sunday, down from 4,475 the previous day, and 111 deaths as infections in the global financial hub continue to drop. | | | | | | A recent rise in Taiwan's domestic COVID-19 cases will not affect plans to gradually re-open as hardly any of the new infections have caused serious illness, Premier Su Tseng-chang said on Sunday. | | | | | | The World Health Organization said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection. | | | | | | Brazilian health agency Anvisa on Saturday issued a new set of rules for incoming international travelers, easing restrictions related to the COVID-19 pandemic as the health crisis subsides in the South American nation. | | | | | | Esther Zhao thought she was doing the right thing when she brought her 2-1/2-year-old daughter to a Shanghai hospital with a fever on March 26. | | | | | | Hong Kong health authorities reported 116 new COVID-19 deaths on Saturday. Daily infections in recent days have continued a steady decline and authorities began easing some of the city's stringent COVID-19 measures. | | | | | | Mainland China reported 2,129 new COVID-19 cases on April 1, up from 1,827 cases a day earlier, the country's national health authority said on Saturday. | | | | | | The U.S. Food and Drug Administration on Friday approved expanded use of Yescarta, a cell therapy made by Gilead Sciences Inc's Kite unit, as a first option after chemotherapy for adults with an advanced, aggressive form of blood cancer. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | |
